表紙:IPVワクチンの世界市場:ワクチンブランド別(POLIOVAC、SHANIPV、POLIORIX、IPOL/IMOVAX、POLYMILEX)、流通チャネル別、地域別-規模、シェア、展望、機会分析(2021年~2028年)
市場調査レポート
商品コード
1069124

IPVワクチンの世界市場:ワクチンブランド別(POLIOVAC、SHANIPV、POLIORIX、IPOL/IMOVAX、POLYMILEX)、流通チャネル別、地域別-規模、シェア、展望、機会分析(2021年~2028年)

IPV Vaccines Market, by Vaccine Brand (POLIOVAC, SHANIPV, POLIORIX, IPOL/IMOVAX, And POLYMILEX), by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 220 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
IPVワクチンの世界市場:ワクチンブランド別(POLIOVAC、SHANIPV、POLIORIX、IPOL/IMOVAX、POLYMILEX)、流通チャネル別、地域別-規模、シェア、展望、機会分析(2021年~2028年)
出版日: 2022年03月09日
発行: Coherent Market Insights
ページ情報: 英文 220 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のIPVワクチン市場は、2021年の1億6,000万米ドルから2028年には2億4,000万米ドルまで増加し、予測期間中に8.5%のCAGRを記録すると予想されています。

様々な政府が、貧しい人々にワクチン接種を提供するため、有益な予防接種プログラムを導入しており、世界の不活化ポリオワクチン(IPV)市場の成長に非常に有利な環境を作り出すと予想されます。

当レポートでは、世界のIPVワクチン市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 調査目的・前提条件

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場の内訳:ワクチンブランド別
    • 市場の内訳:流通チャネル別
    • 市場の内訳:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、および動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • IPVワクチンの採用状況:国別
  • 供給されるIPVワクチン:ユニセフGavi別
  • ポリオワクチン接種の開始と終了の要件
  • 規制市場の貢献(米国、EU5ヶ国、その他)
  • 市場動向
  • 規制シナリオ
  • パイプライン分析
  • 買収
  • PEST分析
  • 公的および私的価格設定-IPVワクチン
  • 疫学

第4章 世界のIPVワクチン市場-コロナウイルス(COVID-19)パンデミックの影響

  • 医療市場に対するCOVID-19の全体的な影響
  • COVID-19疫学

第5章 世界のIPVワクチン市場:ワクチンブランド別(100万米ドル)(2021年~2028年)

  • イントロダクション
  • Poliovac(PFS/SD)
  • Shanipv
  • Poliorix
  • Ipol/Imovax
  • Polymilex

第6章 世界のIPVワクチン市場:流通チャネル別(100万米ドル)(2021年~2028年)

  • イントロダクション
  • 公営
  • 民間

第7章 世界のIPVワクチン市場:地域別(100万米ドル)(2021年~2028年)

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第8章 競合情勢

  • ヒートマップ分析
  • 市場シェア分析
    • GlaxoSmithKline Plc
    • 企業ハイライト
    • 財務実績
    • Sanofi SA
    • 企業ハイライト
    • 財務実績
    • Serum Institute of India Pvt. Ltd.
    • 企業ハイライト
    • 財務実績
    • PT Bio Farma
    • 企業ハイライト
    • 財務実績
    • AJ Vaccines
    • 企業ハイライト
    • 財務実績

第9章 セクション

目次
Product Code: CMI4965

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at US$ 160 Mn in 2021 and is expected to increase to US$ 240 Mn by 2028, registering a CAGR of 8.5% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2019, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

  • This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

  • Global IPV Vaccines Market, by Vaccine Brand:
  • Poliovac (Pfs/Sd)
  • Shanipv
  • Poliorix
  • Ipol/Imovax
  • Polymilex
  • Global IPV Vaccines Market, by Distribution Channel:
  • Private
  • Public
  • Global IPV Vaccines Market, by Region:
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles:
    • GlaxoSmithKline Plc*
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • Sanofi S.A.
    • Serum Institute of India Pvt. Ltd.
    • PT Bio Farma
    • AJ Vaccines

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Vaccine Brand
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • IPV Vaccine Country wise Adoption Status
  • IPV Vaccines Supplied by UNICEF for Gavi
  • Polio Vaccination Entry and Exit Requirements
  • Contribution of Regulated Markets (U.S., EU5, and Others)
  • Market Trends
  • Regulatory Scenario
  • Pipeline Analysis
  • Acquisitions
  • PEST Analysis
  • Public and Private Pricing - IPV Vaccine
  • Epidemiology

4. Global IPV Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact of COVID-19 on Healthcare market
  • COVID-19 Epidemiology

5. Global IPV Vaccines Market, By Vaccine Brand, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Poliovac (PFS/SD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Shanipv
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Poliorix
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Ipol/Imovax
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Polymilex
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global IPV Vaccines Market, By Distribution Channel, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global IPV Vaccines Market, By Region, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2028
  • North America
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2028, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • GlaxoSmithKline Plc
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • Sanofi S.A.
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • Serum Institute of India Pvt. Ltd.
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • PT Bio Farma
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • AJ Vaccines
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact